Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer Jan. 10, 2012
Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409 Jan. 10, 2012
Phase II data presented on PEGylated therapy in previously treated metastatic breast cancer Jan. 5, 2012
RSS